CC BY-NC-ND 4.0 · AJP Rep 2019; 09(03): e298-e301
DOI: 10.1055/s-0039-1697654
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Fetomaternal Bleeding and Neonatal Hematocrit following Cesarean Delivery: Routine versus Transplacental Transection

Emily Gregory
1   Department of Obstetrics & Gynecology, Maternal-Fetal Medicine, University of Tennessee Medical Center, Knoxville, Tennessee
,
Craig V. Towers
1   Department of Obstetrics & Gynecology, Maternal-Fetal Medicine, University of Tennessee Medical Center, Knoxville, Tennessee
,
Jaclyn van Nes
1   Department of Obstetrics & Gynecology, Maternal-Fetal Medicine, University of Tennessee Medical Center, Knoxville, Tennessee
,
Kristina Shumard
1   Department of Obstetrics & Gynecology, Maternal-Fetal Medicine, University of Tennessee Medical Center, Knoxville, Tennessee
,
Kim B. Fortner
1   Department of Obstetrics & Gynecology, Maternal-Fetal Medicine, University of Tennessee Medical Center, Knoxville, Tennessee
,
Beth Weitz
1   Department of Obstetrics & Gynecology, Maternal-Fetal Medicine, University of Tennessee Medical Center, Knoxville, Tennessee
› Institutsangaben
Funding This study was funded through the University of Tennessee Physician's Medical Education and Research Foundation.
Weitere Informationen

Publikationsverlauf

01. Juli 2019

09. Juli 2019

Publikationsdatum:
19. September 2019 (online)

Abstract

Objective To evaluate fetomaternal bleeding following routine cesarean delivery compared with cesarean delivery involving transplacental transection.

Study Design A prospective cohort study evaluating cesarean delivery in which the placenta was transected (cases) versus controls (placenta not transected) from January 2016 to April 2018. A maternal Kleihauer–Betke's (KB) test and newborn hematocrit were performed shortly after delivery.

Results The rate of a positive KB test was not significantly different between cases (n = 31) and controls (n = 61) (19 vs. 14%; odds ratio [OR]: 1.44; 95% confidence interval [CI]: 0.46–4.49; p = 0.74). Median neonatal hematocrits were not different. However, the rate of newborn hematocrits <40% at delivery was higher in cases compared with controls (23 vs. 3%; OR: 8.90; 95% CI: 1.72–45.90; p = 0.005).

Conclusion A cesarean requiring transplacental transection to accomplish delivery does not significantly increase the rate of fetomaternal bleeding but is associated with a higher likelihood of newborn hematocrit <40% at delivery.

Paper Presentation

Oral presentation, 2018 Annual Meeting, Central Association of Obstetricians Gynecologists, October 17–20, 2018, in Minneapolis, MN.


 
  • References

  • 1 Bowman JM. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?. Am J Obstet Gynecol 1985; 151 (03) 289-294
  • 2 Balderston KD, Towers CV, Rumney PJ, Montgomery D. Is the incidence of fetal-to-maternal hemorrhage increased in patients with third-trimester bleeding?. Am J Obstet Gynecol 2003; 188 (06) 1615-1618 , discussion 1618–1621
  • 3 Dhanraj D, Lambers D. The incidences of positive Kleihauer-Betke test in low-risk pregnancies and maternal trauma patients. Am J Obstet Gynecol 2004; 190 (05) 1461-1463
  • 4 Ghidini A, Korker V. Fetal complication after external cephalic version at term: case report and literature review. J Matern Fetal Med 1999; 8 (04) 190-192
  • 5 Katiyar R, Kriplani A, Agarwal N, Bhatla N, Kabra M. Detection of fetomaternal hemorrhage following chorionic villus sampling by Kleihauer Betke test and rise in maternal serum alpha feto protein. Prenat Diagn 2007; 27 (02) 139-142
  • 6 Banerjee K, Kriplani A, Kumar V, Rawat KS, Kabra M. Detecting fetomaternal hemorrhage after first-trimester abortion with the Kleihauer-Betke test and rise in maternal serum alpha-fetoprotein. J Reprod Med 2004; 49 (03) 205-209
  • 7 Lubusky M, Simetka O, Studnickova M, Prochazka M, Ordeltova M, Vomackova K. Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section. Transfusion 2012; 52 (09) 1977-1982
  • 8 Adeniji AO, Mabayoje VO, Raji AA, Muhibi MA, Tijani AA, Adeyemi AS. Feto - maternal haemorrhage in parturients: incidence and its determinants. J Obstet Gynaecol 2008; 28 (01) 60-63
  • 9 Salim R, Ben-Shlomo I, Nachum Z, Mader R, Shalev E. The incidence of large fetomaternal hemorrhage and the Kleihauer-Betke test. Obstet Gynecol 2005; 105 (5 Pt 1): 1039-1044
  • 10 Feldman N, Skoll A, Sibai B. The incidence of significant fetomaternal hemorrhage in patients undergoing cesarean section. Am J Obstet Gynecol 1990; 163 (03) 855-858
  • 11 Perslev A, Jørgensen FS, Nielsen LK, Berkowicz A, Dziegiel MH. Fetomaternal hemorrhage in women undergoing elective cesarean section. Acta Obstet Gynecol Scand 2011; 90 (03) 253-257
  • 12 Ross MG. Fetal exsanguination from lower segment cesarean section: techniques revisited. JSM Clin Case Rep 2017; 5 (01) 1126-1127
  • 13 Leavitt BG, Huff DL, Bell LA, Thurnau GR. Placental drainage of fetal blood at cesarean delivery and feto maternal transfusion: a randomized controlled trial. Obstet Gynecol 2007; 110 (03) 608-611
  • 14 Fernandes BJ, von Dadelszen P, Fazal I, Bansil N, Ryan G. Flow cytometric assessment of feto-maternal hemorrhage; a comparison with Betke-Kleihauer. Prenat Diagn 2007; 27 (07) 641-643
  • 15 Savithrisowmya S, Singh M, Kriplani A, Agarwal N, Mehra NK, Bhatla N. Assessment of fetomaternal hemorrhage by flow cytometry and Kleihauer-Betke test in Rh-negative pregnancies. Gynecol Obstet Invest 2008; 65 (02) 84-88
  • 16 Meleti D, Caetano AC, Boute T. , et al. Assessment of fetomaternal hemorrhage by Kleihauer-Betke test, flow cytometry and α-fetoprotein after invasive obstetric procedures. Clin Exp Obstet Gynecol 2012; 39 (03) 303-306
  • 17 Kim YA, Makar RS. Detection of fetomaternal hemorrhage. Am J Hematol 2012; 87 (04) 417-423